One of the underlying processes of NSCLC is the over-expression of the anti-apoptotic protein Bcl-2 and the low expression of the apoptosis-promoting protein Bax, which slows down cell death and extends the cell survival [25,26]. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.